Acer Medical Inc. (TPEX:6857)
Taiwan · Delayed Price · Currency is TWD 92.80
0.00 (0.00%)
Jul 21, 2026, 1:14 PM CST
Acer Medical Market Cap
Acer Medical has a market cap or net worth of 1.41 billion as of July 21, 2026. Its market cap has decreased by -23.31% in one year.
Market Cap
1.41B
Enterprise Value
1.24B
Revenue
60.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
92.80
ChartMarket Cap Chart
Since October 27, 2021, Acer Medical's market cap has increased from 720.00M to 1.41B, an increase of 96.25%. That is a compound annual growth rate of 15.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 1.41B | -6.26% |
| Dec 31, 2025 | 1.51B | -30.28% |
| Dec 30, 2024 | 2.16B | -23.66% |
| Dec 29, 2023 | 2.83B | 154.79% |
| Dec 30, 2022 | 1.11B | -1.98% |
| Dec 21, 2021 | 1.13B | 57.50% |
| Oct 27, 2021 | 720.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 492.63B |
| Caliway Biopharmaceuticals | 161.08B |
| Pell Bio-Med Technology | 66.74B |
| Heron Neutron Medical | 65.51B |
| GenMont Biotech Incorporation | 1.40B |
| TaiRx | 1.40B |
| Advagene Biopharma | 1.39B |
| Bioptik Technology Incorporation | 1.36B |